Clincosm LogoSign in Get a demo

neurofibromatosis type 1

Showing 26 - 50 of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

Recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • London, United Kingdom
  • +1 more
Nov 11, 2021

Neurofibromatosis Type 1 Trial in Salt Lake City (Plyometric training program)

Completed
  • Neurofibromatosis Type 1
  • Plyometric training program
  • Salt Lake City, Utah
  • +1 more
Mar 18, 2021

Neurofibromatosis Type 1, Muscle Weakness Trial in Manchester (Whole-body vibration, Muscle strengthening exercises)

Completed
  • Neurofibromatosis Type 1
  • Muscle Weakness
  • Whole-body vibration
  • Muscle strengthening exercises
  • Manchester, United Kingdom
    Manchester University Hospitals NHS Foundation Trust
Mar 15, 2021

Neurofibromatosis Type 1, Brain Tumor, Glioma Trial in Cleveland (Magnetic Resonance Imaging, Magnetic Resonance Fingerprinting)

Terminated
Has Results
  • Neurofibromatosis Type 1
  • +2 more
  • Magnetic Resonance Imaging
  • Magnetic Resonance Fingerprinting
  • Cleveland, Ohio
    Rainbow Babies and Children's Hospital
Dec 18, 2020

Function of the Pigment Epithelium in Type 1 Neurofibromatosis

Completed
  • Neurofibromatosis Type 1
  • Electro-oculogram
  • Full-field electroretinogram
  • Paris, France
    Hôpital Necker-Enfants Malades
Jan 7, 2021

NCI Pediatric Oncology Branch Research Study

Completed
  • Ewing Sarcoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 7, 2020

    Neurofibromatosis Type 1 Trial in Leuven, Rotterdam, Barcelona (Lamotrigine, Placebo)

    Terminated
    • Neurofibromatosis Type 1
    • Leuven, Belgium
    • +2 more
    Apr 10, 2020

    Adaptation and Quality of Life Among Neurofibromatosis Type I

    Completed
    • Neurofibromatosis Type 1
    • +2 more
      • Bethesda, Maryland
        National Human Genome Research Institute (NHGRI), 9000 Rockville
      Dec 13, 2019

      Neurofibromatosis Type 1 Trial in Saint Louis (Magnetic resonance imaging, Gadolinium contrast)

      Terminated
      • Neurofibromatosis Type 1
      • Magnetic resonance imaging
      • Gadolinium contrast
      • Saint Louis, Missouri
        Washington University School of Medicine (St. Louis Children's H
      Aug 29, 2019

      Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients

      Completed
      • Neurofibromatosis Type 1
        • Salt Lake City, Utah
          Shriners Hospitals for Children, Salt Lake City
        Feb 21, 2019

        Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia

        Completed
        • Neurofibromatosis Type 1
        • Tibial Dysplasia
          • Salt Lake City, Utah
            Shriners Hospitals for Children, Intermountain Hospital
          Feb 21, 2019

          Constitutional Mismatch-repair Deficiency Among Suspected

          Unknown status
          • Neurofibromatosis Type 1
            • (no location specified)
            Nov 27, 2018

            Neurofibromatosis Type 1, Sarcoma Trial in United States (biological, drug, procedure, radiation)

            Completed
            Has Results
            • Neurofibromatosis Type 1
            • Sarcoma
            • filgrastim
            • +5 more
            • Birmingham, Alabama
            • +16 more
            Sep 14, 2018

            Neurofibromatosis Type 1, Precancerous Condition Trial in Philadelphia (Methotrexate, Vinblastine)

            Completed
            Has Results
            • Neurofibromatosis Type 1
            • Precancerous Condition
            • Philadelphia, Pennsylvania
              Children's Hospital of Philadelphia
            Jul 13, 2018

            Neurofibromatosis Type 1 Trial in Toulouse (Neuropsychological evaluation, Evaluation of the reading assistance technique)

            Unknown status
            • Neurofibromatosis Type 1
            • Neuropsychological evaluation
            • Evaluation of the reading assistance technique
            • Toulouse, France
              University Hospital Toulouse
            Jul 10, 2018

            Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

            Completed
            • Neurofibromatosis Type 1
              • Salt Lake City, Utah
                University Health Care, 50 North Medical Drive
              Apr 30, 2018

              Neurofibromatosis Type 1 Trial in Australia, United States (Lovastatin ™, )

              Completed
              Has Results
              • Neurofibromatosis Type 1
              • Lovastatin ™
              • placebo
              • Birmingham, Alabama
              • +11 more
              Mar 8, 2018

              Neurofibromatosis Type 1 Trial in United States (Sirolimus)

              Completed
              Has Results
              • Neurofibromatosis Type 1
              • Birmingham, Alabama
              • +8 more
              Oct 12, 2017

              Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma Trial in United States (Cediranib Maleate)

              Terminated
              Has Results
              • Neurofibromatosis Type 1
              • +2 more
              • Cediranib Maleate
              • Birmingham, Alabama
              • +8 more
              Jul 21, 2017

              Neurofibromatosis Type 1 Trial in Saint Louis

              Completed
              • Neurofibromatosis Type 1
                • Saint Louis, Missouri
                  Washington University
                Jul 21, 2017

                Neurofibromatosis Type 1 Brain Tumor Genetic Risk

                Completed
                • Neurofibromatosis Type 1
                • Pediatric Brain Tumor
                  • Saint Louis, Missouri
                    Washington University
                  May 8, 2017

                  Neurofibromatosis Type 1, Cutaneous Neurofibromas Trial in Boston (Imiquimod 5% Cream)

                  Completed
                  • Neurofibromatosis Type 1
                  • Cutaneous Neurofibromas
                  • Imiquimod 5% Cream
                  • Boston, Massachusetts
                    Massachusetts General Hospital
                  Jan 9, 2017

                  Neurofibromatosis Type 1, Cutaneous Neurofibromas Trial in Boston (Ranibizumab)

                  Completed
                  • Neurofibromatosis Type 1
                  • Cutaneous Neurofibromas
                  • Boston, Massachusetts
                    Massachusetts General Hospital
                  Jul 6, 2016

                  Neurofibromatosis Type 1 Trial in Créteil, Nantes (Neuropsychological examination and quality of life measures)

                  Completed
                  • Neurofibromatosis Type 1
                  • Neuropsychological examination and quality of life measures
                  • Créteil, France
                  • +1 more
                  Jul 5, 2016

                  Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical

                  Unknown status
                  • Cutaneous Neurofibromas
                  • +2 more
                  • Skin Biopsy
                  • Grand Rapids, Michigan
                    Spectrum Health Hospital Group
                  May 17, 2016